![]() |
Magna International Inc. 337 Magna Drive Aurora, Ontario L4G 7K1 Tel (905) 726-2462 Fax (905) 726-7164 |
• | Evaluated the effectiveness of controls over management’s process for determining the fair value of technology, including management’s controls over the forecasted revenues and the selection of the discount rate; |
• | Evaluated the reasonableness of forecasted revenues by comparing the assumptions used in the projections to external market sources, historical data and results from other areas of the audit; |
• | With the assistance of fair value specialists, evaluated the reasonableness of the discount rate by testing the source information underlying the determination of the discount rate and developing a range of independent estimates and comparing those to the discount rate selected by management. |
Note |
2023 |
2022 | ||||||||||
Sales |
$ |
$ | ||||||||||
Costs and expenses |
||||||||||||
Cost of goods sold |
||||||||||||
Selling, general and administrative |
||||||||||||
Depreciation |
||||||||||||
Amortization of acquired intangible assets |
||||||||||||
Interest expense, net |
16 | |||||||||||
Equity income |
( |
) |
( |
) | ||||||||
Other expense, net |
4 | |||||||||||
Income from operations before income taxes |
||||||||||||
Income taxes |
12 | |||||||||||
Net income |
||||||||||||
Income attributable to non-controlling interests |
( |
) |
( |
) | ||||||||
Net income attributable to Magna International Inc. |
$ |
$ | ||||||||||
Earnings per Common Share: |
5 | |||||||||||
Basic |
$ |
$ | ||||||||||
Diluted |
$ |
$ | ||||||||||
Weighted average number of Common Shares outstanding during the year [in millions]: |
5 | |||||||||||
Basic |
||||||||||||
Diluted |
||||||||||||
Note |
2023 |
2022 | ||||||||||
Net income |
$ |
$ | ||||||||||
|
|
|
|
|||||||||
Other comprehensive income (loss), net of tax: |
21 | |||||||||||
Net unrealized gain (loss) on translation of net investment in foreign operations |
( |
) | ||||||||||
Net unrealized gain on cash flow hedges |
||||||||||||
Reclassification of net gain on cash flow hedges to net income |
( |
) |
( |
) | ||||||||
Reclassification of net loss on pensions to net income |
||||||||||||
Reclassification of loss on translation of net investment in foreign operations to income |
||||||||||||
Pension and post-retirement benefits |
( |
) |
||||||||||
|
|
|
|
|||||||||
Other comprehensive income (loss) |
( |
) | ||||||||||
|
|
|
|
|||||||||
Comprehensive income |
||||||||||||
Comprehensive income attributable to non-controlling interests |
( |
) |
( |
) | ||||||||
|
|
|
|
|||||||||
Comprehensive income attributable to Magna International Inc. |
$ |
$ |
||||||||||
|
|
|
|
Note |
2023 |
2022 | ||||||||||
ASSETS |
||||||||||||
Current assets |
||||||||||||
Cash and cash equivalents |
6 | $ |
$ | |||||||||
Accounts receivable |
||||||||||||
Inventories |
8 | |||||||||||
Prepaid expenses and other |
||||||||||||
Investments |
9 | |||||||||||
Fixed assets, net |
10 | |||||||||||
Operating lease right-of-use |
17 | |||||||||||
Intangible assets, net |
13 | |||||||||||
Goodwill |
11 | |||||||||||
Other assets |
14, 18 | |||||||||||
Deferred tax assets |
12 | |||||||||||
$ |
$ | |||||||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||||||
Current liabilities |
||||||||||||
Short-term borrowing |
$ |
$ | ||||||||||
Accounts payable |
||||||||||||
Other accrued liabilities |
15 | |||||||||||
Accrued salaries and wages |
||||||||||||
Income taxes payable |
||||||||||||
Long-term debt due within one year |
16 | |||||||||||
Current portion of operating lease liabilities |
17 | |||||||||||
Long-term debt |
16 | |||||||||||
Operating lease liabilities |
17 | |||||||||||
Long-term employee benefit liabilities |
18 | |||||||||||
Other long-term liabilities |
19 | |||||||||||
Deferred tax liabilities |
12 | |||||||||||
Shareholders’ equity |
||||||||||||
Common Shares [issued: 2023 – |
20 | |||||||||||
Contributed surplus |
||||||||||||
Retained earnings |
||||||||||||
Accumulated other comprehensive loss |
21 | ( |
) |
( |
) | |||||||
Non-controlling interests |
||||||||||||
$ |
$ | |||||||||||
On behalf of the Board: | ||||
/s/ “Peter Bowie” |
/s/ “Robert F. MacLellan” | |||
Director | Chairman of the Board |
Note |
2023 |
2022 | ||||||||||
OPERATING ACTIVITIES |
||||||||||||
Net income |
$ |
$ | ||||||||||
Items not involving current cash flows |
6 | |||||||||||
Changes in operating assets and liabilities |
6 | ( |
) | |||||||||
Cash provided from operating activities |
||||||||||||
INVESTMENT ACTIVITIES |
||||||||||||
Acquisitions |
7 | ( |
) |
( |
) | |||||||
Fixed asset additions |
( |
) |
( |
) | ||||||||
Increase in investments, other assets and intangible assets |
( |
) |
( |
) | ||||||||
Increase in public and private equity investments |
( |
) |
( |
) | ||||||||
Proceeds from dispositions |
||||||||||||
Net cash (outflow) inflow from disposal of facilities |
4 | ( |
) |
|||||||||
Cash used for investing activities |
( |
) |
( |
) | ||||||||
FINANCING ACTIVITIES |
||||||||||||
Issues of debt |
16 | |||||||||||
Increase in short-term borrowings |
||||||||||||
Repayments of debt |
16 | ( |
) |
( |
) | |||||||
Issue of Common Shares on exercise of stock options |
||||||||||||
Tax withholdings on vesting of equity awards |
( |
) |
( |
) | ||||||||
Repurchase of Common Shares |
20 | ( |
) |
( |
) | |||||||
Contributions to subsidiaries by non-controlling interests |
||||||||||||
Dividends paid to non-controlling interests |
( |
) |
( |
) | ||||||||
Dividends |
( |
) |
( |
) | ||||||||
Cash provided from (used for) financing activities |
( |
) | ||||||||||
Effect of exchange rate changes on cash and cash equivalents |
( |
) |
( |
) | ||||||||
Net decrease in cash, cash equivalents during the year |
( |
) |
( |
) | ||||||||
Cash and cash equivalents, beginning of year |
||||||||||||
Cash and cash equivalents, end of year |
6 | $ |
$ | |||||||||
Common Shares |
Contri- |
Non- |
||||||||||||||||||||||||||
Number |
Stated Value |
buted Surplus |
Retained Earnings |
AOCL [i] |
controlling Interests |
Total Equity |
||||||||||||||||||||||
[in millions] |
||||||||||||||||||||||||||||
Balance, December 31, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||
Other comprehensive loss |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
Contribution by non-controlling interests |
||||||||||||||||||||||||||||
Purchase of non-controlling interests |
( |
) | ( |
) | ||||||||||||||||||||||||
Shares issued on exercise of stock options |
( |
) | ||||||||||||||||||||||||||
Release of stock and stock units |
( |
) | — | |||||||||||||||||||||||||
Tax withholdings on vesting of equity awards |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Repurchase and cancellation under normal course issuer bids [note 20] |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||
Business combinations |
||||||||||||||||||||||||||||
Dividends paid to non-controlling interests |
( |
) | ( |
) | ||||||||||||||||||||||||
Dividends paid [$ |
( |
) | ( |
) | ||||||||||||||||||||||||
Balance, December 31, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||
Other comprehensive income |
( |
) | ||||||||||||||||||||||||||
Contribution by non-controlling interests |
||||||||||||||||||||||||||||
Shares issued on exercise of stock options |
( |
) | ||||||||||||||||||||||||||
Release of stock and stock units |
( |
) | — | |||||||||||||||||||||||||
Tax withholdings on vesting of equity awards |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Repurchase and cancellation under normal course issuer bids [note20] |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||
Dividends paid to non-controlling interests |
( |
) | ( |
) | ||||||||||||||||||||||||
Dividends paid [$ |
( |
) | ( |
) | ||||||||||||||||||||||||
Balance, December 31, 2023 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||||||||
(i) |
AOCL is Accumulated Other Comprehensive Loss. |
1. |
NATURE OF OPERATIONS AND BASIS OF PRESENTATION |
2. |
SIGNIFICANT ACCOUNTING POLICIES |
3. |
ACCOUNTING STANDARDS |
4. |
OTHER EXPENSE, NET |
2023 |
2022 | |||||||
Investments [a] |
$ |
$ | ||||||
Restructuring [b] |
||||||||
Veoneer Active Safety Business transaction costs [c] |
||||||||
Impairments and loss on sale of operations in Russia [d] |
||||||||
Loss on sale of business [e] |
||||||||
Impairments [f] |
||||||||
Other expense, net |
$ |
$ | ||||||
[a] |
Investments |
2023 |
2022 | |||||||
Revaluation of public company warrants |
$ |
$ | ||||||
Non-cash impairment charges [i] |
||||||||
Revaluation of public and private equity investments |
||||||||
Net gain on sale of public equity investments |
( |
) | ||||||
Other expense, net |
||||||||
Tax effect |
( |
) |
( |
) | ||||
Net loss attributable to Magna |
$ |
$ | ||||||
[i] | The non-cash impairment charges relate to impairments of private equity investments and related long-term receivables within Other assets. |
[b] |
Restructuring |
[c] |
Veoneer Active Safety Business transaction costs |
[d] |
Impairments and loss on sale of operations in Russia |
[e] |
Loss on sale of business |
[f] |
Impairments |
5. |
EARNINGS PER SHARE |
2023 |
2022 | |||||||
Basic earnings per Common Share: |
||||||||
Net income attributable to Magna International Inc. |
$ |
$ | ||||||
Weighted average number of Common Shares outstanding during the year |
||||||||
Basic earnings per Common Share |
$ |
$ | ||||||
Diluted earnings per Common Share [a]: |
||||||||
Net income attributable to Magna International Inc. |
$ |
$ | ||||||
Weighted average number of Common Shares outstanding during the year |
||||||||
Stock options and restricted stock |
||||||||
Diluted earnings per Common Share |
$ |
$ | ||||||
[a] | Diluted earnings per Common Share exclude “in-the-money”. two-class method was excluded from the calculation of earnings per share because the effect would be immaterial. |
6. |
DETAILS OF CASH FROM OPERATING ACTIVITIES |
[a] | Cash and cash equivalents consist of: |
2023 |
2022 | |||||||
Bank term deposits and bankers' acceptances |
$ |
$ | ||||||
Cash |
||||||||
$ |
$ | |||||||
[b] | Items not involving current cash flows: |
2023 |
2022 | |||||||
Depreciation |
$ |
$ | ||||||
Amortization of acquired intangible assets |
||||||||
Amortization of other assets and intangible assets included in cost of goods sold |
||||||||
Deferred revenue amortization |
( |
) |
( |
) | ||||
Other non-cash charges |
||||||||
Deferred tax recovery |
( |
) |
( |
) | ||||
Equity income less than (in excess of) dividends received |
( |
) | ||||||
Non-cash portion of Other expense, net [note 4] |
||||||||
$ |
$ | |||||||
[c] | Changes in operating assets and liabilities: |
2023 |
2022 | |||||||
Accounts receivable |
$ |
( |
) |
$ | ( |
) | ||
Inventories |
( |
) |
( |
) | ||||
Prepaid expenses and other |
( |
) | ||||||
Accounts payable |
||||||||
Accrued salaries and wages |
( |
) |
||||||
Other accrued liabilities |
||||||||
Income taxes receivable |
( |
) |
( |
) | ||||
$ |
$ | ( |
) | |||||
7. |
BUSINESS COMBINATIONS |
[a] |
Veoneer AS |
Non-cash working capital |
$ | |||
Fixed assets |
||||
Other assets |
||||
Intangible assets |
||||
Goodwill |
||||
Other liabilities |
( |
) | ||
Deferred tax liabilities |
( |
) | ||
Purchase price |
||||
Receivable from seller |
||||
Net cash outflow |
$ | |||
[b] |
Magna Yuma |
8. |
INVENTORIES |
2023 |
2022 | |||||||
Raw materials and supplies |
$ |
$ | ||||||
Work-in-process |
||||||||
Finished goods |
||||||||
Tooling and engineering |
||||||||
$ |
$ | |||||||
9. |
INVESTMENTS |
2023 |
2022 | |||||||
Equity method investments [a] |
$ |
$ | ||||||
Public and private equity investments |
||||||||
Warrants [b] |
||||||||
Debt investments |
||||||||
$ |
$ | |||||||
[a] | The ownership percentages and carrying values of the Company’s principal equity method investments at December 31 were as follows [in millions, except percentages]: |
2023 |
2022 | |||||||||||
LG Magna e-Powertrain Co., Ltd. [i] |
% |
$ |
$ | |||||||||
Litens Automotive Partnership [ii] |
% |
$ |
$ | |||||||||
Hubei HAPM Magna Seating Systems Co., Ltd. |
% |
$ |
$ | |||||||||
BAIC BluePark Magna Automobile Co., Ltd. |
% |
$ |
$ |
[i] | LG Magna e-Powertrain [“LGM”] is a variable interest entity [‘‘VIE’’] and depends on the Company and LG Electronics for any additional cash needs. The Company cannot make key operating decisions considered the most significant to the VIE, and is therefore not the primary beneficiary. The Company’s known maximum exposure to loss approximated the carrying value of its investment balance as at December 31, 2023. |
[ii] | The Company accounts for its investments under the equity method of accounting as a result of significant participating rights that prevent control. |
[b] | In October 2020, the Company signed agreements with Fisker Inc. [“Fisker”] for the platform sharing, engineering and manufacturing of the Fisker Ocean SUV. In connection with the arrangement, Fisker issued approximately |
2023 |
2022 | |||||||
Current assets |
$ |
$ | ||||||
Non-current assets |
$ |
$ | ||||||
Current liabilities |
$ |
$ | ||||||
Long-term liabilities |
$ |
$ | ||||||
2023 |
2022 | |||||||
Sales |
$ |
$ | ||||||
Cost of goods sold & expenses |
||||||||
Net income |
$ |
$ | ||||||
10. |
FIXED ASSETS |
2023 |
2022 | |||||||
Cost |
||||||||
Land |
$ |
$ | ||||||
Buildings |
||||||||
Machinery and equipment |
||||||||
Accumulated depreciation |
||||||||
Buildings |
( |
) |
( |
) | ||||
Machinery and equipment |
( |
) |
( |
) | ||||
$ |
$ | |||||||
11. |
GOODWILL |
Body Exteriors & Structures |
Power & Vision |
Seating Systems |
Complete Vehicles |
Corporate |
Total |
|||||||||||||||||||
Balance, December 31, 2021 |
||||||||||||||||||||||||
Acquisitions [note 7] |
||||||||||||||||||||||||
Foreign exchange and other |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Balance, December 31, 2022 |
||||||||||||||||||||||||
Acquisitions [note 7] |
||||||||||||||||||||||||
Foreign exchange and other |
( |
) |
||||||||||||||||||||||
Balance, December 31, 2023 |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
12. |
INCOME TAXES |
[a] | The provision for income taxes differs from the expense that would be obtained by applying the Canadian statutory income tax rate as a result of the following: |
2023 |
2022 | |||||||
Canadian statutory income tax rate |
% |
% | ||||||
Tax on repatriation of foreign earnings |
||||||||
Net effect of losses not benefited |
||||||||
Non-taxable capital losses (gains) |
( |
) | ||||||
Reserve for uncertain tax positions |
||||||||
Earnings of equity accounted investees |
( |
) |
( |
) | ||||
Foreign exchange re-measurement |
( |
) |
( |
) | ||||
Deductible inflationary adjustments |
( |
) |
( |
) | ||||
Valuation allowance on deferred tax assets |
( |
) |
( |
) | ||||
Foreign rate differentials |
( |
) |
||||||
Research and development tax credits |
( |
) |
( |
) | ||||
Others |
||||||||
Effective income tax rate |
% |
% | ||||||
[b] | The details of income (loss) before income taxes by jurisdiction are as follows: |
2023 |
2022 | |||||||
Canadian |
$ |
( |
) |
$ | ( |
) | ||
Foreign |
||||||||
$ |
$ | |||||||
[c] | The details of the income tax provision are as follows: |
2023 |
2022 | |||||||
Current |
||||||||
Canadian |
$ |
$ | ||||||
Foreign |
||||||||
Deferred |
||||||||
Canadian |
( |
) |
( |
) | ||||
Foreign |
( |
) |
( |
) | ||||
( |
) |
( |
) | |||||
$ |
$ | |||||||
[d] | Deferred income taxes have been provided on temporary differences, which consist of the following: |
2023 |
2022 | |||||||
Tax depreciation in excess of (less than) book depreciation |
$ |
$ |
( |
) | ||||
Tax on undistributed foreign earnings |
( |
) | ||||||
Re-measurement of deferred tax assets |
( |
) |
( |
) | ||||
Net tax losses (benefit) utilization |
( |
) |
||||||
Unrealized loss on remeasurement of investments |
( |
) |
( |
) | ||||
Change in valuation allowance on deferred tax assets |
( |
) |
( |
) | ||||
Net (increase) decrease in non-deductible liabilities |
( |
) |
||||||
Book amortization in excess of tax amortization |
( |
) |
( |
) | ||||
Others |
( |
) |
( |
) | ||||
$ |
( |
) |
$ | ( |
) | |||
[e] | Deferred tax assets and liabilities consist of the following temporary differences: |
2023 |
2022 | |||||||
Assets |
||||||||
Tax benefit of loss carryforwards |
$ |
$ | ||||||
Liabilities currently not deductible for tax |
||||||||
Operating lease liabilities |
||||||||
Other assets tax value in excess of book value |
||||||||
Tax credit carryforwards |
||||||||
Unrealized losses on remeasurement of investments |
||||||||
Unrealized loss on foreign exchange hedges and retirement liabilities |
||||||||
Others |
||||||||
Valuation allowance against tax benefit of loss carryforwards |
( |
) |
( |
) | ||||
Other valuation allowance |
( |
) |
( |
) | ||||
$ |
$ | |||||||
Liabilities |
||||||||
Operating lease right-of-use assets |
||||||||
Tax depreciation in excess of book depreciation |
||||||||
Tax on undistributed foreign earnings |
||||||||
Unrealized gain on foreign exchange hedges and retirement liabilities |
||||||||
Net deferred tax assets |
$ |
$ | ||||||
2023 |
2022 |
|||||||
Long-term deferred tax assets |
$ |
$ | ||||||
Long-term deferred tax liabilities |
( |
) |
( |
) | ||||
$ |
$ | |||||||
[f] | Deferred income taxes have not been provided on $ |
[g] | Income taxes paid in cash [net of refunds] were $ |
[h] | As at December 31, 2023, the Company had domestic and foreign operating loss carryforwards of $ |
[i] | As at December 31, 2023 and 2022, the Company’s gross unrecognized tax benefits were $ |
2023 |
2022 | |||||||
Balance, beginning of year |
$ |
$ | ||||||
Increase based on tax positions related to current year |
||||||||
Decrease based on tax positions of prior years |
( |
) | ||||||
Settlements |
( |
) | ||||||
Foreign currency translation |
( |
) | ||||||
Statute expirations |
( |
) |
( |
) | ||||
Acquisitions [note 7] |
||||||||
$ |
$ | |||||||
13. |
INTANGIBLE ASSETS |
Remaining weighted average useful life in years |
2023 |
2022 | ||||||||||
Cost |
||||||||||||
Customer relationship intangibles |
$ |
$ | ||||||||||
Patents and Technology |
||||||||||||
Computer software and other licenses |
||||||||||||
Accumulated depreciation |
||||||||||||
Customer relationship intangibles |
( |
) |
( |
) | ||||||||
Patents and Technology |
( |
) |
( |
) | ||||||||
Computer software and other licenses |
( |
) |
( |
) | ||||||||
$ |
$ | |||||||||||
14. |
OTHER ASSETS |
2023 |
2022 | |||||||
Preproduction costs related to long-term supply agreements |
$ |
$ | ||||||
Long-term receivables |
||||||||
Unrealized gain on cash flow hedges [note 22] |
||||||||
Pension overfunded status [note 18[a]] |
||||||||
Other |
||||||||
$ |
$ | |||||||
15. |
WARRANTY |
2023 |
2022 | |||||||
Balance, beginning of year |
$ |
$ | ||||||
Expense, net |
||||||||
Settlements |
( |
) |
( |
) | ||||
Business combination [note 7] |
||||||||
Foreign exchange and other |
( |
) | ||||||
$ |
$ | |||||||
16. |
DEBT |
[a] | Credit Facilities |
[b] |
Commercial Paper Program |
[a] | The Company’s long-term debt, net of unamortized issuance costs, is substantially uncollateralized and consists of the following: |
2023 |
2022 | |||||||
Senior Notes [note 16 [c]] |
||||||||
$ |
$ |
|||||||
$ |
||||||||
$ |
||||||||
€ |
||||||||
$ |
||||||||
Cdn$ |
||||||||
€ |
||||||||
$ |
||||||||
€ |
||||||||
Bank term debt at a weighted average interest rate of [note 16 [d]] |
||||||||
Government loans at a weighted average interest rate of |
||||||||
Other |
||||||||
Less due within one year |
||||||||
$ |
$ | |||||||
[b] | Future principal repayments on long-term debt are estimated to be as follows: |
2024 |
$ |
|||
2025 |
||||
2026 |
||||
2027 |
||||
2028 |
||||
Thereafter |
||||
$ |
||||
[c] | During the first quarter of 2023, the Company issued the following Senior Notes: |
Issuance Date |
Maturity Date | |||
Cdn$ |
||||
€ |
||||
$ |
||||
$ |
[d] | On March 6, 2023, the Company entered into a syndicated, unsecured, delayed draw term loan [the “Term Loan”] with a 3-year tranche and $5-year tranche of the Term Loan. The amounts are drawn in advances of 1, 3 or 6-month loans and may be rolled over until the end of the 3- and 5-year terms. The remaining balance of the facility was subsequently cancelled. |
[e] | On April 27, 2023, the Company amended its $ |
[f] | Interest expense, net includes: |
2023 |
2022 | |||||||
Interest expense |
||||||||
Current |
$ |
$ | ||||||
Long-term |
||||||||
Interest income |
( |
) |
( |
) | ||||
Interest expense, net |
$ |
$ | ||||||
[g] | Interest paid in cash was $ |
17. |
LEASES |
[a] | The Company has entered into leases primarily for real estate, manufacturing equipment and vehicles with terms that range from |
2023 |
||||||||
Operating lease expense |
$ |
$ |
||||||
Short-term lease expense |
||||||||
Variable lease expense |
||||||||
Total lease expense |
$ |
$ |
||||||
2023 |
2022 |
|||||||
Operating cash flows – cash paid |
$ |
$ |
||||||
New right-of-use assets |
$ |
$ |
||||||
Weighted-average remaining lease term |
||||||||
Weighted-average discount rate |
% |
% |
[b] | Operating lease liabilities consist of: |
Current operating liabilities |
$ |
$ |
||||||
Non-current operating lease liabilities |
||||||||
Total lease liabilities |
$ |
$ |
||||||
[c] | Future annual payments for operating leases are as follows: |
2023 [i] |
||||
2024 |
$ |
|||
2025 |
||||
2026 |
||||
2027 |
||||
2028 |
||||
Thereafter |
||||
Less: amount representing interest |
||||
Total lease liabilities |
$ |
|||
[i] | Excludes $ |
[d] | The Company’s finance leases were not material for any of the periods presented. |
18. |
LONG-TERM EMPLOYEE BENEFIT LIABILITIES |
2023 |
2022 | |||||||
Defined benefit pension plans and other [a] |
$ |
$ | ||||||
Termination and long-term service arrangements [b] |
||||||||
Retirement medical benefits plans [c] |
||||||||
Other long-term employee benefits |
||||||||
Long-term employee benefit obligations |
$ |
$ | ||||||
[a] |
Defined benefit pension plans |
2023 |
2022 | |||||||
Projected benefit obligation |
||||||||
Discount rate |
% |
% | ||||||
Rate of compensation increase |
% |
% | ||||||
Net periodic benefit cost |
||||||||
Discount rate |
% |
% | ||||||
Rate of compensation increase |
% |
% | ||||||
Expected return on plan assets |
% |
% |
2023 |
2022 | |||||||
Projected benefit obligation |
||||||||
Beginning of year |
$ |
$ | ||||||
Current service cost |
||||||||
Interest cost |
||||||||
Actuarial gains and changes in actuarial assumptions |
( |
) | ||||||
Benefits paid |
( |
) |
( |
) | ||||
Acquisition [note 7] |
||||||||
Divestiture |
( |
) |
||||||
Foreign exchange |
( |
) | ||||||
End of year |
||||||||
Plan assets at fair value [i] |
||||||||
Beginning of year |
||||||||
Return on plan assets |
( |
) | ||||||
Employer contributions |
||||||||
Benefits paid |
( |
) |
( |
) | ||||
Foreign exchange |
( |
) | ||||||
End of year |
||||||||
Ending funded status – Plan deficit |
$ |
$ | ||||||
Amounts recorded in the consolidated balance sheet |
||||||||
Non-current asset [note 14] |
$ |
$ | ||||||
Current liability |
||||||||
Non-current liability |
||||||||
Net liability |
$ |
$ | ||||||
Amounts recorded in accumulated other comprehensive income Unrecognized actuarial losses |
$ |
( |
) |
$ | ( |
) | ||
Net periodic benefit cost |
||||||||
Current service cost |
$ |
$ | ||||||
Interest cost |
||||||||
Return on plan assets |
( |
) |
( |
) | ||||
Actuarial losses |
||||||||
Net periodic benefit cost |
$ |
$ | ||||||
[i] | The asset allocation of the Company’s defined benefit pension plans at December 31, 2023 and the target allocation range for 2024 are as follows: |
2024 |
2023 | |||||||
Fixed income securities | % |
% | ||||||
Equity securities | % |
% | ||||||
Cash and cash equivalents |
% |
% | ||||||
% |
% | |||||||
[b] |
Termination and long-term service arrangements |
2023 |
2022 |
|||||||
Discount rate |
% |
% | ||||||
Rate of compensation increase |
% |
% |
2023 |
2022 | |||||||
Projected benefit obligation |
||||||||
Beginning of year |
$ |
$ | ||||||
Current service cost |
||||||||
Interest cost |
||||||||
Actuarial losses (gains) and changes in actuarial assumptions |
( |
) | ||||||
Benefits paid |
( |
) |
( |
) | ||||
Foreign exchange |
( |
) | ||||||
|
|
|
|
|||||
Ending funded status – Plan deficit |
$ |
$ | ||||||
|
|
|
|
|||||
Amounts recorded in the consolidated balance sheet |
||||||||
Current liability |
$ |
$ | ||||||
Non-current liability |
||||||||
|
|
|
|
|||||
Net liability |
$ |
$ | ||||||
|
|
|
|
|||||
Amounts recorded in accumulated other comprehensive income Unrecognized actuarial losses |
$ |
( |
) |
$ | ( |
) | ||
|
|
|
|
|||||
Net periodic benefit cost |
||||||||
Current service cost |
$ |
$ | ||||||
Interest cost |
||||||||
Actuarial losses |
||||||||
|
|
|
|
|||||
Net periodic benefit cost |
$ |
$ | ||||||
|
|
|
|
[c] |
Retirement medical benefits plans |
2023 |
2022 |
|||||||
Retirement medical benefit obligations |
% |
% | ||||||
Net periodic benefit cost |
% |
% | ||||||
Health care cost inflation |
% |
% |
2023 |
2022 |
|||||||
Projected benefit obligation |
||||||||
Beginning of year |
$ |
$ |
||||||
Interest cost |
||||||||
Employer contributions |
||||||||
Actuarial gains and changes in actuarial assumptions |
( |
) |
( |
) | ||||
Benefits paid |
( |
) |
( |
) | ||||
Foreign exchange |
||||||||
|
|
|
|
|||||
Ending funded status – Plan deficit |
$ |
$ |
||||||
|
|
|
|
|||||
Amounts recorded in the consolidated balance sheet |
||||||||
Current liability |
$ |
$ |
||||||
Non-current liability |
||||||||
|
|
|
|
|||||
Net liability |
$ |
$ |
||||||
|
|
|
|
|||||
Amounts recorded in accumulated other comprehensive income |
||||||||
Unrecognized actuarial gains |
$ |
$ |
||||||
|
|
|
|
|||||
Net periodic benefit cost |
||||||||
Interest cost |
$ |
$ |
||||||
Actuarial gains |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Net periodic benefit cost |
$ |
$ |
||||||
|
|
|
|
[d] |
Future benefit payments |
Defined benefit pension plans |
Termination and long service arrangements |
Retirement medical benefits plans |
Total | |||||||||||||
Expected employer contributions - 2024 |
$ | $ | $ | $ | ||||||||||||
Expected benefit payments: |
||||||||||||||||
2024 |
$ | $ | $ | $ | ||||||||||||
2025 |
||||||||||||||||
2026 |
||||||||||||||||
2027 |
||||||||||||||||
2028 |
||||||||||||||||
Thereafter |
||||||||||||||||
$ | $ | $ | $ | |||||||||||||
19. |
OTHER LONG-TERM LIABILITIES |
2023 |
2022 | |||||||
Long-term portion of income taxes payable |
$ |
$ | ||||||
Long-term portion of deferred revenue |
||||||||
Asset retirement obligation |
||||||||
Long-term portion of fair value of hedges [note 21] |
||||||||
Other |
||||||||
$ |
$ | |||||||
20. |
CAPITAL STOCK |
[a] | At December 31, 2023, the Company’s authorized, issued and outstanding capital stock are as follows: |
[i] | Each share is entitled to |
[ii] | Each share shall participate equally as to dividends. |
[b] | The Company had Normal Course Issuer Bid in place for the 12-month periods beginning November 2021 and 2022. |
2023 |
2022 | |||||||||||||||
Shares purchased |
Cash amount |
Shares purchased |
Cash amount |
|||||||||||||
2021 Bid |
$ |
$ | ||||||||||||||
2022 Bid |
||||||||||||||||
$ |
$ | |||||||||||||||
[c] | The following table presents the maximum number of shares that would be outstanding if all the dilutive instruments outstanding at February 22, 2024 were exercised or converted: |
Common Shares |
||||
Stock options [i] |
||||
[i] | Options to purchase Common Shares are exercisable by the holder in accordance with the vesting provisions and upon payment of the exercise price as may be determined from time to time pursuant to the Company’s stock option plans. |
21. |
ACCUMULATED OTHER COMPREHENSIVE LOSS |
2023 |
2022 |
|||||||
Accumulated net unrealized loss on translation of net investment in foreign operations |
||||||||
Balance, beginning of year |
$ |
( |
) |
$ |
( |
) | ||
Net unrealized gain (loss) |
( |
) | ||||||
Repurchase of shares under Normal Course Issuer Bids [note 20] |
( |
) |
||||||
Recognition of cumulative translation adjustment loss in Russia [note 4] |
||||||||
Balance, end of year |
( |
) |
( |
) | ||||
Accumulated net unrealized gain on cash flow hedges [b] |
||||||||
Balance, beginning of year |
||||||||
Net unrealized gain |
||||||||
Reclassification of net gain to net income [a] |
( |
) |
( |
) | ||||
Balance, end of year |
||||||||
Accumulated net unrealized loss on other long-term liabilities [b] |
||||||||
Balance, beginning of year |
( |
) |
( |
) | ||||
Net unrealized (loss) gains |
( |
) |
||||||
Reclassification of net loss to net income [a] |
||||||||
Balance, end of year |
( |
) |
( |
) | ||||
Total accumulated other comprehensive loss [c] |
$ |
( |
) |
$ |
( |
) | ||
[a] | The effects on net income of amounts reclassified from AOCL, with presentation location, were as follows: |
2023 |
2022 |
|||||||
Cash flow hedges |
||||||||
Sales |
$ |
( |
) |
$ |
( |
) | ||
Cost of sales |
||||||||
Income tax |
( |
) |
( |
) | ||||
Net of tax |
||||||||
Other long-term liabilities |
||||||||
Cost of sales |
( |
) |
( |
) | ||||
Income tax |
||||||||
Net of tax |
( |
) |
( |
) | ||||
Total net gain reclassified to net income |
$ |
$ |
||||||
[b] | The amount of income tax (loss) benefit that has been allocated to each component of other comprehensive loss is as follows: |
2023 |
2022 | |||||||
Accumulated net unrealized loss on translation of net investment in foreign operations |
$ |
$ | ||||||
Accumulated net unrealized gain on cash flow hedges |
||||||||
Balance, beginning of year |
( |
) | ||||||
Net unrealized (loss) gain |
( |
) |
||||||
Reclassification of net loss to net income |
||||||||
Balance, end of year |
( |
) |
||||||
Accumulated net unrealized loss on other long-term liabilities |
||||||||
Balance, beginning of year |
||||||||
Net unrealized gain (loss) |
( |
) | ||||||
Reclassification of net gain to net income |
( |
) | ||||||
Balance, end of year |
||||||||
Total income tax (loss) benefit |
$ |
( |
) |
$ | ||||
[c] | The amount of other comprehensive gain that is expected to be reclassified to net income during 2024 is $ |
22. |
FINANCIAL INSTRUMENTS |
[a] |
Foreign exchange contracts |
For Canadian dollars | For U.S. dollars | For euros | ||||||||||||||||||||||||||||||
Buy (Sell) |
U.S. dollar amount |
Weighted average rate |
Peso amount |
Weighted average rate |
U.S. dollar amount |
Weighted average rate |
Czech Koruna amount |
Weighted average rate |
||||||||||||||||||||||||
2024 |
||||||||||||||||||||||||||||||||
2024 |
( |
) | — | ( |
) | — | — | |||||||||||||||||||||||||
2025 |
— | — | ||||||||||||||||||||||||||||||
2025 |
( |
) | — | — | ( |
) | — | — | ||||||||||||||||||||||||
2026 |
( |
) | — | — | — | — | — | — | ||||||||||||||||||||||||
( |
) | ( |
) | |||||||||||||||||||||||||||||
[b] |
Financial assets and liabilities |
2023 |
2022 | |||||||
Financial assets |
||||||||
Cash and cash equivalents |
$ |
$ | ||||||
Accounts receivable |
||||||||
Warrants and public and private equity investments |
||||||||
Long-term receivables included in other assets [note 14] |
||||||||
|
|
|
|
|||||
$ |
$ | |||||||
|
|
|
|
|||||
Financial liabilities |
||||||||
Short-term borrowing |
$ |
$ | ||||||
Long-term debt (including portion due within one year) |
||||||||
Accounts payable |
||||||||
|
|
|
|
|||||
$ |
$ | |||||||
|
|
|
|
|||||
Derivatives designated as effective hedges, measured at fair value |
||||||||
Foreign currency contracts |
||||||||
Prepaid expenses |
$ |
$ | ||||||
Other assets |
||||||||
Other accrued liabilities |
( |
) |
( |
) | ||||
Other long-term liabilities |
( |
) |
( |
) | ||||
|
|
|
|
|||||
$ |
$ | |||||||
|
|
|
|
[c] |
Derivatives designated as effective hedges, measured at fair value |
Gross amounts presented in consolidated balance sheets |
Gross amounts not offset in consolidated balance sheets |
Net amounts |
||||||||||
December 31, 2023 |
||||||||||||
Assets |
$ | $ | $ | |||||||||
Liabilities |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
|||||||
December 31, 2022 |
||||||||||||
Assets |
$ | $ | $ | |||||||||
Liabilities |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
[d] |
Supplier financing program |
[e] |
Fair value |
[f] |
Credit risk |
[g] |
Currency risk |
[h] |
Interest rate risk |
[i] |
Equity price risk |
23. |
CONTINGENCIES |
[a] | In December 2023, the Company received a notification [the “Notification Letter”] from a customer informing the Company as to the customer’s initial determination that one of the Company’s operating groups bears responsibility for costs totaling $ |
[b] | The Company’s policy is to comply with all applicable laws, including antitrust and competition laws. Based on a previously completed global review of legacy antitrust risks which led to a September 2020 settlement with the European Commission and a June 2022 settlement with Brazil’s federal competition authority involving in both cases the supply of closure systems, Magna does not currently anticipate any material liabilities. However, the Company could be subject to restitution settlements, civil proceedings, reputational damage and other consequences, including as a result of the matters specifically referred to above. |
24. |
SEGMENTED INFORMATION |
[a] | Magna is a mobility technology company and a global supplier in the automotive space. Magna has complete vehicle engineering and contract manufacturing expertise, as well as product capabilities which include body, chassis, exterior, seating, powertrain, active driver assistance, electronics, mechatronics, mirrors, lighting and roof systems. Magna also has electronic and software capabilities across many of these areas. |
[b] | The following tables show segment information for the Company’s reporting segments and a reconciliation of Adjusted EBIT to the Company’s consolidated income before income taxes: |
2023 |
||||||||||||||||||||
Total sales |
External sales |
Adjusted EBIT |
Depreciation |
Equity loss (income) |
||||||||||||||||
Body Exteriors & Structures |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
Power & Vision |
( |
) | ||||||||||||||||||
Seating Systems |
( |
) | ||||||||||||||||||
Complete Vehicles |
( |
) | ||||||||||||||||||
Corporate & Other [i] |
( |
) |
( |
) |
||||||||||||||||
Total Reportable Segments |
$ |
$ |
$ |
$ |
$ |
( |
) | |||||||||||||
2022 | ||||||||||||||||||||
Total sales |
External sales |
Adjusted EBIT |
Depreciation | Equity loss (income) |
||||||||||||||||
Body Exteriors & Structures |
$ | $ | $ | $ | $ | |||||||||||||||
Power & Vision |
( |
) | ||||||||||||||||||
Seating Systems |
( |
) | ||||||||||||||||||
Complete Vehicles |
( |
) | ||||||||||||||||||
Corporate & Other [i] |
( |
) | ||||||||||||||||||
Total Reportable Segments |
$ | $ | $ | $ | $ | ( |
) | |||||||||||||
2023 |
||||||||||||||||||||
Net assets |
Investments |
Goodwill |
Fixed assets, net |
Fixed asset additions |
||||||||||||||||
Body Exteriors & Structures |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
Power & Vision |
||||||||||||||||||||
Seating Systems |
||||||||||||||||||||
Complete Vehicles |
||||||||||||||||||||
Corporate & Other |
||||||||||||||||||||
Total Reportable Segments |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
2022 | ||||||||||||||||||||
Net assets | Investments | Goodwill | Fixed assets, net |
Fixed asset additions |
||||||||||||||||
Body Exteriors & Structures |
$ | $ | $ | $ | $ | |||||||||||||||
Power & Vision |
||||||||||||||||||||
Seating Systems |
||||||||||||||||||||
Complete Vehicles |
||||||||||||||||||||
Corporate & Other |
||||||||||||||||||||
Total Reportable Segments |
$ | $ | $ | $ | $ | |||||||||||||||
[i] | Included in Corporate and Other Adjusted EBIT are intercompany fees charged to the automotive segments. |
[c] | The following table reconciles Net income from operations to Adjusted EBIT: |
2023 |
2022 | |||||||
Net Income |
$ |
$ | ||||||
Add: |
||||||||
Amortization of acquired intangible assets |
||||||||
Interest expense, net |
||||||||
Other expense, net |
||||||||
Income taxes |
||||||||
Adjusted EBIT |
$ |
$ | ||||||
[d] | The following table reconciles Total Assets to Net Assets: |
2023 |
2022 | |||||||
Total Assets |
$ |
$ | ||||||
Deduct assets not included in segment net assets: |
||||||||
Cash and cash equivalents |
( |
) |
( |
) | ||||
Deferred tax assets |
( |
) |
( |
) | ||||
Long-term receivables from joint venture partners |
( |
) |
( |
) | ||||
Deduct liabilities included in segment net assets: |
||||||||
Accounts payable |
( |
) |
( |
) | ||||
Accrued salaries and wages |
( |
) |
( |
) | ||||
Other accrued liabilities |
( |
) |
( |
) | ||||
Segment Net Assets |
$ |
$ | ||||||
[e] | The following table aggregates external revenues by customer as follows: |
2023 |
2022 | |||||||
General Motors |
$ |
$ | ||||||
Daimler AG |
||||||||
BMW |
||||||||
Ford Motor Company |
||||||||
Stellantis |
||||||||
Volkswagen |
||||||||
Other |
||||||||
$ |
$ | |||||||
[f] | The following table summarizes external revenues and long-lived assets by geographic region: |
External Sales |
Fixed Assets, Net |
|||||||||||||||
2023 |
2022 | 2023 |
2022 | |||||||||||||
North America |
||||||||||||||||
United States |
$ |
$ | $ |
$ | ||||||||||||
Mexico |
||||||||||||||||
Canada |
||||||||||||||||
Europe |
||||||||||||||||
Austria |
||||||||||||||||
Germany |
||||||||||||||||
Czech Republic |
||||||||||||||||
Poland |
||||||||||||||||
Italy |
||||||||||||||||
United Kingdom |
||||||||||||||||
Spain |
||||||||||||||||
France |
||||||||||||||||
Turkey |
||||||||||||||||
Sweden |
||||||||||||||||
Slovakia |
||||||||||||||||
Other Europe |
||||||||||||||||
Asia Pacific |
||||||||||||||||
China |
||||||||||||||||
India |
||||||||||||||||
Other Asia Pacific |
||||||||||||||||
Rest of World |
||||||||||||||||
$ |
$ | $ |
$ | |||||||||||||